Professor, Psychiatry, University of Michigan Medical School
Medical Genetics
Dr. Melvin G. McInnis, MD
|
|
Give Review
Melvin McInnis practices Medical Genetics. He has 1 awards "CMS Meaningful Use Stage 1 Certification". Melvin G. McInnis is a published MD. He published 62 publications, including: 'Baseline disability and poor functioning in bipolar disorder predict worse outcomes: results from the Bipolar CHOICE study.' He accepts Medicare.
Publications
- A tool to predict suicidal ideation and behavior in bipolar Disorder: The Concise Health Risk Tracking Self-Report.
- Bipolar CHOICE (Clinical Health Outcomes Initiative in Comparative Effectiveness): a pragmatic 6-month trial of lithium versus quetiapine for bipolar Disorder.
- Baseline disability and poor functioning in bipolar Disorder predict worse outcomes: results from the Bipolar CHOICE study.
- A reduced risk of stroke with lithium exposure in bipolar Disorder: a population-based retrospective cohort study.
- Medical burden in bipolar Disorder: findings from the Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder study (Bipolar CHOICE).
- Shared dimensions of performance and activation dysfunction in cognitive control in females with mood Disorders.
- Bipolar Disorders in the Arab world: a critical review.
- Psychotherapy use in bipolar Disorder: Association with functioning and illness severity.
- Complexity of Illness and Adjunctive Benzodiazepine Use in Outpatients With Bipolar I or II Disorder: Results From the Bipolar CHOICE Study.
- Induced Pluripotent Stem Cell (iPSC) Models of Bipolar Disorder.
- Corrigendum to "Effect of adjunctive benzodiazepines on clinical outcomes in lithium- or quetiapine-treated outpatients with bipolar I or II Disorder: Results from the...
- Openness predicts cognitive functioning in bipolar Disorder.
- Effect of adjunctive benzodiazepines on clinical outcomes in lithium- or quetiapine-treated outpatients with bipolar I or II Disorder: results from the Bipolar CHOICE ...
- The role of social relationships in bipolar Disorder: A review.
- Dietary intake and plasma metabolomic analysis of polyunsaturated fatty acids in Bipolar subjects reveal dysregulation of linoleic acid metabolism.
- Gender differences, clinical correlates, and longitudinal outcome of bipolar Disorder with comorbid migraine.
- The double burden of age and disease on cognition and quality of life in bipolar Disorder.
- Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder (Bipolar CHOICE): A pragmatic trial of complex treatment for a complex Disorder.
- Can P300 distinguish among schizophrenia, schizoaffective and bipolar I Disorders? An ERP study of response inhibition.
- Association of exercise with quality of life and mood symptoms in a comparative effectiveness study of bipolar Disorder.
- Emotion perception and executive functioning predict work status in euthymic bipolar Disorder.
- C9ORF72 expansion in a family with bipolar Disorder.
- Enrichment of cis-regulatory gene expression SNPs and methylation quantitative trait loci among bipolar Disorder susceptibility variants.
- Gene expression alterations in bipolar Disorder postmortem brains.
- Reduced Emotion Processing Efficiency in Healthy Males Relative to Females.
- Association of plasma omega-3 and omega-6 lipids with burden of disease measures in Bipolar subjects.
- Differential executive functioning performance by phase of bipolar Disorder.
- Greater executive and visual memory dysfunction in comorbid bipolar Disorder and substance use Disorder.
- Fats and factors: lipid profiles associate with personality factors and suicidal history in Bipolar subjects.
- Associations between suicide attempts and elevated bedtime salivary cortisol levels in bipolar Disorder.
- Genome-Wide Association of Bipolar Disorder Suggests an Enrichment of Replicable Associations in Regions near Genes.
- Modality-specific alterations in the perception of emotional stimuli in Bipolar Disorder compared to Healthy Controls and Major Depressive Disorder.
- Association of plasma interleukin-18 levels with emotion regulation and μ-opioid neurotransmitter function in Major depression and healthy volunteers.
- Bayesian EM algorithm for scoring polymorphic deletions from SNP data and application to a common CNV on 8q24.
- Singleton deletions throughout the genome increase risk of bipolar Disorder.
- Paradigms lost: rethinking psychiatry in the postgenome era.
- Family-based SNP association study on 8q24 in bipolar Disorder.
- Familiality and diagnostic patterns of subphenotypes in the National Institutes of Mental Health Bipolar sample.
- SNP fine mapping of chromosome 8q24 in bipolar Disorder.
- Attempted suicide in bipolar Disorder pedigrees: evidence for linkage to 2p12.
- Genetics of recurrent early-onset Major depression (GenRED): final genome scan report.
- Genetics of recurrent early-onset Major depression (GenRED): significant linkage on chromosome 15q25-q26 after fine mapping with single nucleotide polymorphism markers.
- Prioritizing Disease Genes by Analysis of Common Elements (PDG-ACE).
- Differential expression of disrupted-in-schizophrenia (DISC1) in bipolar Disorder.
- Familial aggregation of illness chronicity in recurrent, early-onset Major depression pedigrees.
- Clinical correlates and familial aggregation of age at onset in bipolar Disorder.
- Assessment of the effect of age at onset on linkage to bipolar Disorder: evidence on chromosomes 18p and 21q.
- Combined analysis from eleven linkage studies of bipolar Disorder provides strong evidence of susceptibility loci on chromosomes 6q and 8q.
- Lack of support for a genetic association of the XBP1 promoter polymorphism with bipolar Disorder in probands of European origin.
- Loci on chromosomes 6q and 6p interact to increase susceptibility to bipolar affective Disorder in the national institute of mental health genetics initiative pedigrees.
- Genomewide significant linkage to recurrent, early-onset major depressive Disorder on chromosome 15q.
- Genome-wide scan and conditional analysis in bipolar Disorder: evidence for genomic interaction in the National Institute of Mental Health genetics initiative bipolar ...
- Genome scan of the fifty-six Bipolar pedigrees from the NIMH genetics initiative replication sample: chromosomes 4, 7, 9, 18, 19, 20, and 21.
- Genome scan meta-analysis of schizophrenia and bipolar Disorder, part III: Bipolar Disorder.
- Genetics of recurrent early-onset depression (GenRED): design and preliminary clinical characteristics of a repository sample for genetic linkage studies.
- Suggestive linkage to chromosomal regions 13q31 and 22q12 in families with psychotic bipolar Disorder.
- Additional, physically ordered markers increase linkage signal for bipolar Disorder on chromosome 18q22.
- Familial aggregation of psychotic symptoms in a replication set of 69 bipolar Disorder pedigrees.
- Diagnostic reliability of bipolar II Disorder.
- Studies of anticipation in bipolar affective Disorder.
- Tablet-based screening of Depressive symptoms in quito, ecuador: efficiency in primary care.
Schools
Johns Hopkins University School Of Medicine
Procedures Preformed
- Family Psychotherapy
- Group Psychotherapy
- Psychiatric Evaluation
- Psychotherapy and Psychophysiological Therapy (incl. Biofeedback)
Conditions Treated
- Adjustment Disorder
- Alcoholism (Alcohol Dependence)
- Amphetamine and Other Psychostimulant Dependence
- Anxiety
- View All
Doctors Specialties
- Clinical Genetics
- Psychiatry
- Medical Genetics
Accepted Insurances
- Choice Plus POS II
- Amerigroup (Wellpoint)
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Blue Care Network PCP Focus Network
- Group Employees PPO
- Cigna
- Cofinity PPO
- Commercial Insurance Company
- First Health (Coventry Health Care) PPO
- GEHA
- Health Alliance
- Preferred PPO
- Humana
- Medicaid
- Medicare MCR
- Molina
- MultiPlan PPO
- PHCS Network PPO
- NGS CoreSource
- PHP-Physicians Health Plan
- Priority PPO
- Tricare
- United Healthcare
- Wells Fargo Insurance
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Iceland
Hospital
-
University of Michigan Hospitals and Health Centers
Drug Facts
| NPI NUMBER | 1295807113 | |
| NPPES Provider LastName | MCINNIS | |
| NPPES Provider FirstName | MELVIN | |
| NPPES Provider ZIPCode | 481092700 | |
| NPPES Provider State | MI | |
| Specialty Description | Psychiatry | |
| Total Claim Count | 25.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1295807113 |
| Last Name Of The Provider | MCINNIS |
| First Name Of The Provider | MELVIN |
| View All |
Similar Doctors
|
|
Dr. Shane C. Quinonez, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey W. Innis, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Ralph H. Stern, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas D. Gelehrter, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Mason Barr Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Donna M. Martin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John K. Fink, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Catherine E. Keegan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John A. Bernat, MD |
|
|
Dr. Cara M. Fosdick, MD
This Doctor is OpenDoctor Recommended.
|